Characteristics of hospitalizations and emergency department visits due to generalized pustular psoriasis in the United States [0.03%]
美国关于天疱疮型银屑病住院及急诊就诊特征的研究
Maya L Hanna,David Singer,Shaun D Bender et al.
Maya L Hanna et al.
Objectives: Generalized pustular psoriasis (GPP) is a rare and severe, inflammatory skin disease. GPP is characterized by recurrent flares that consist of disseminated erythematous skin rash with sterile neutrophil-filled...
Prevalence, incidence and economic burden of schizophrenia among Medicaid beneficiaries [0.03%]
医疗补助受益人的精神分裂症患病率、发病率和经济负担
Dominic Pilon,Charmi Patel,Marie-Hélène Lafeuille et al.
Dominic Pilon et al.
Objective: To estimate the prevalence, incidence and economic burden of schizophrenia among Medicaid beneficiaries. Methods: Annual pre...
Ulrike Hostalek,Ian Campbell
Ulrike Hostalek
We have conducted a narrative review based on a structured search strategy, focusing on the effects of metformin on the progression of non-diabetic hyperglycemia to clinical type 2 diabetes mellitus. The principal trials that demonstrated a...
The impact of caring for an individual with aromatic l-amino acid decarboxylase (AADC) deficiency: a qualitative study and the development of a conceptual model [0.03%]
关怀芳香族L-氨基酮酸脱羧酶缺乏症患者的影响：定性研究及概念模型的发展
Hanna Skrobanski,Kate Williams,Christian Werner et al.
Hanna Skrobanski et al.
Background: Aromatic l-amino acid decarboxylase (AADC) deficiency is a rare neurological condition, associated with a wide range of symptoms and functional issues, such as profound motor impairment and learning disability...
Real world effectiveness and satisfaction with secukinumab in the treatment of patients with psoriatic arthritis: a population survey in five European countries [0.03%]
关于银屑病关节炎患者的苏金单抗疗效及患者满意度的真实世界研究：五国人群调查结果
Philip G Conaghan,Dorothy L Keininger,Elizabeth A Holdsworth et al.
Philip G Conaghan et al.
Objectives: To describe the effectiveness of secukinumab in the treatment of psoriatic arthritis (PsA) and associated physician satisfaction with secukinumab treatment, in routine clinical practice across five European co...
Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma [0.03%]
CARTITUDE-1与KarMMa研究中cilta-cel治疗复发/难治性多发性骨髓瘤的疗效结局的匹配调整间接比较
Tom Martin,Saad Z Usmani,Jordan M Schecter et al.
Tom Martin et al.
Objective: This study estimated the comparative efficacy of ciltacabtagene autoleucel (cilta-cel) versus the approved idecabtagene vicleucel (ide-cel) dose range of 300-460 × 106 CAR-positive T-cells for the treatment of...
Helen Senderovich,Briam Jimenez Lopez
Helen Senderovich
Background: Parkinson's disease is a progressive neurodegenerative disorder that negatively impacts the lives of affected people. The therapeutic benefits of treatment only decrease going forward from the time of diagnosi...
Comparing the downstream costs and healthcare utilization associated with the use of low-dose computed tomography (LDCT) in lung cancer screening in patients with and without alzheimer's disease and related dementias (ADRD) [0.03%]
比较低剂量计算机断层扫描（LDCT）在阿尔茨海默病和痴呆以及非痴呆患者中肺癌筛查的下游成本和医疗利用率差异
Yahan Zhang,Jiang Bian,Jinhai Huo et al.
Yahan Zhang et al.
Objective: This study aims to compare the downstream costs and healthcare utilization associated with using low-dose computed tomography (LDCT) for lung cancer screening in patients with and without Alzheimer's disease an...
Epidemiology of skin event rates among users of pumps for the subcutaneous administration of drugs for chronic conditions [0.03%]
慢性病患者皮下给药泵使用者的皮肤病事件流行率研究
Susan S Jick,Denise M Oleske,Rebecca Persson et al.
Susan S Jick et al.
Objective: To provide the epidemiology of skin events occurring during long-term administration of medications delivered by continuous subcutaneous infusion pump (CSIP) systems as background rates for the development of n...
Matching-adjusted indirect treatment comparison of onasemnogene abeparvovec and nusinersen for the treatment of symptomatic patients with spinal muscular atrophy type 1 [0.03%]
针对脊髓性肌萎缩症1型有症状患者的onasemnogene abeparvovec与nusinersen的匹配调整间接治疗比较
Matthias Bischof,Maria Lorenzi,Jennifer Lee et al.
Matthias Bischof et al.
Objective: Onasemnogene abeparvovec, a one-time intravenous gene replacement therapy, and nusinersen, an antisense oligonucleotide that requires ongoing intrathecal administration, have been evaluated as treatments for sp...